We have previously shown that compound UAMC-2526, a low micromolar ATG4B inhibitor, inhibits tumor growth in a mouse HT-29 tumor xenograft model of human colorectal cancer by inhibiting ATG4B (33). This evidence concerns the gene ATG4B and colorectal cancer.